MDoutlook is a leading disease intelligence company.
We build the success of your organization through better decision-making.


Specializing in oncology, rare and ultra-rare diseases, we answer your business questions using custom market research instruments, our proprietary disease panels, our client side experience and our depth of clinical understanding.


Driven by staff medical experts, our team engages with ThoughtLeaders and the right clinicians to deliver real-world, actionable insights.


Our solutions
MDoutlook provides custom and syndicated market research, ThoughtLeader identification and network mapping, and guaranteed physician engagement.


Click on the above icons to explore how our clients derive value.

What's New at MDoutlook

Value of medicines is number one concern for oncologists

21 Mar 2019

Financial impact and affordability of medicines is the number one concern for oncologists in our 2019 Leadership research in ImmunoOncology. Oncologists were asked to choose…


1 in 3 oncologists do not have a clear leader in patient support programs

14 Mar 2019

Our 2019 Leadership study in ImmunoOncology shows that 1 in 3 oncologists (across the US and EU) are not sufficiently aware of different patient support…


Oncologists value Bio-Pharma's commercial and marketing activities

07 Mar 2019

Having revealed the top attributes for successful leadership in ImmunoOncology, MDoutlook’s latest release reveals that specific commercial and marketing activities influence about 25% of oncologists’…


What's Trending in Oncology (updated hourly)